President-elect Donald Trump has announced his selection of Dr. Marty Makary to serve as the commissioner for the Food and Drug Administration (FDA). In a statement, Trump expressed his belief that the FDA has lost the trust of Americans and strayed from its core mission as a regulatory body.
Dr. Makary, a highly respected surgical oncologist and health policy expert from Johns Hopkins, has been chosen to lead the FDA in a new direction. Trump emphasized the need for course correction and refocusing within the Agency, citing Dr. Makary's expertise as essential to achieving these goals.
Under the guidance of Robert F. Kennedy Jr., Dr. Makary will be tasked with evaluating harmful chemicals present in the nation's food supply, as well as assessing the safety of drugs and biologics administered to young Americans. The overarching aim is to address the Childhood Chronic Disease Epidemic that has been a growing concern.
Trump expressed confidence in Dr. Makary's ability to restore the FDA to a gold standard of scientific research. He highlighted Dr. Makary's career-long dedication to providing high-quality, cost-effective care as a key factor in his selection. The President-elect also emphasized the importance of streamlining bureaucratic processes within the FDA to ensure that Americans have timely access to necessary medical cures and treatments.
